Skip to content
PICO Portalanswers from OpenAlex

Dissecting childhood asthma with nasal transcriptomics distinguishes subphenotypes of disease

PaperCitations, authors & open-access status

Dissecting childhood asthma with nasal transcriptomics distinguishes subphenotypes of disease is a paper indexed in PICO Portal from OpenAlex.

How many citations does Dissecting childhood asthma with nasal transcriptomics distinguishes subphenotypes of disease have?

PICO Portalcitation count

Dissecting childhood asthma with nasal transcriptomics distinguishes subphenotypes of disease has 271 citations in the OpenAlex counts PICO Portal stores.

When was Dissecting childhood asthma with nasal transcriptomics distinguishes subphenotypes of disease published?

PICO Portalyear

Dissecting childhood asthma with nasal transcriptomics distinguishes subphenotypes of disease has 2014 year in the PICO Portal index.

What is the open-access status of Dissecting childhood asthma with nasal transcriptomics distinguishes subphenotypes of disease?

PICO Portaloa status

Dissecting childhood asthma with nasal transcriptomics distinguishes subphenotypes of disease has closed oa status in the PICO Portal index.

What is the DOI of Dissecting childhood asthma with nasal transcriptomics distinguishes subphenotypes of disease?

PICO Portaldoi

The DOI for Dissecting childhood asthma with nasal transcriptomics distinguishes subphenotypes of disease is on the source record.

What is the PMID of Dissecting childhood asthma with nasal transcriptomics distinguishes subphenotypes of disease?

PICO Portalpmid

The PMID for Dissecting childhood asthma with nasal transcriptomics distinguishes subphenotypes of disease is on the source record.

What is the OpenAlex record for Dissecting childhood asthma with nasal transcriptomics distinguishes subphenotypes of disease?

PICO Portalopenalex

The OpenAlex for Dissecting childhood asthma with nasal transcriptomics distinguishes subphenotypes of disease is on the source record.

Related on PICO Portal

470M+ articles · 14-day free trial